Reducing Treatment Burden in IBD with At-Home Therapy Options : Episode 2

Efficacy and Safety of Subcutaneous Infliximab

August 7, 2024

Opinion

Video

A key opinion leader analyzes the clinical remission and endoscopic response data from the LIBERTY CD and LIBERTY UC trials for subcutaneous infliximab-dyyb injection, contrasts it with intravenous infliximab, and evaluates the drug's safety and efficacy profile.

EP: 1.Reducing Treatment Burden in IBD with At-Home Therapy Options

Now Viewing

EP: 2.Efficacy and Safety of Subcutaneous Infliximab

EP: 3.Patient Selection and Switching Patients to Subcutaneous Infliximab

What are the key findings regarding the clinical remission and endoscopic response of subcutaneous infliximab-dyyb injection from the LIBERTY CD and LIBERTY UC trials?
How does subcutaneous infliximab injection compare to IV infliximab in terms of sustenance of drug levels?
- Are there any clinical advantages of the subcutaneous delivery over the IV route?
How does the safety profile of subcutaneous infliximab injection compare to IV infliximab?